期刊文献+

登革病毒样颗粒疫苗的研究现状

Review of study on Dengue virus-like particles vaccine
下载PDF
导出
摘要 登革病毒引起的疾病是一种严重威胁人类健康的蚊媒性急性传染病。但至今仍没有获批准的疫苗可用。近年,一种新的病毒样颗粒(VLPs)能使免疫小鼠产生中和性抗体和持久、特异的T淋巴免疫记忆细胞。VLPs克服了传统疫苗的很多不足,具有较大应用潜力。 The infection caused by Dengue virus is an acute life-threatening mosquito-borne infectious disease. So far, an effective and safe vaccine for dengue is not yet available. Recently a new virus-like particles vaccine was developed which induces the vaccinated mice to produce neutralizing antibody, and long-lasting virus-specific mem- ory T lymphocytes. What more, it also can be widely explored by using yeast expression system. Its special priori- ties make it become a hopeful ideal dengue vaccine.
出处 《基础医学与临床》 CSCD 北大核心 2013年第7期927-930,共4页 Basic and Clinical Medicine
关键词 登革病毒 病毒样颗粒 疫苗 蚊媒性传染病 dengue virus virus-like particles vaccine mosquito-borue infectious disease
  • 相关文献

参考文献12

  • 1Azevedo AS, Yamamura AM, Freire MS,et al. DNA vac- cines against dengue virus type 2 based on truncate enve- lope protein or its domain Ill [ J ]. PLoS One, 2011, 6 : e20528.
  • 2Shang W, Liu J, Yang J,et al. Dengue virus-like particles: construction and application [ J ]. App| Microbiol Biotechn- o1,2012 ,94 :39 - 46.
  • 3Qing M, Liu W, Yuan Z, et al. A high-throughput assay u- sing dengue-I virus-like particles for drug discovery [ J ].Antiviral Res, 2010,86 : 163 - 171.
  • 4Rothman AL. Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms[J]. Nat Rev lm- munol, 2011, 11:532 -543.
  • 5Mendonqa LS, Mendonqa ML, Parrode N, et al. Splenic rupture in dengue hemorrhagic Fever: report of a case and review[J]. Jpn J Infect Dis, 2011, 64:330-332.
  • 6Shang W, Liu J, Hu Z, et al. Dengue virus-like particles: construction and application[ J]. Appl Microbiol Biotechn-ol, 2012, 94:39-46.
  • 7Zhang S, Liang M, Gu W,et al. Vaccination with dengue virus-like particles induces humoral and cellular immune re- sponses in mice[J]. VirolJ, 2011, 30:333.
  • 8Watterson D, Kobe B, Young PR. Residues in domain III of the dengue virus envelope glycoprotein involved in cell-sur- face glycosaminoglycan binding[ J ]. J Gen Viro1,2012,93 : 72 - 82.
  • 9Roldao A, Mellado MC, Castilho LR, et al. Virus-like par- ticles in vaccine development [ J ]. Expert Rev Vaccines, 2010, 9:1149 - !176.
  • 10Yang JJ,Jiang WH,Yang S. mazF as a counter-selectable marker for unmarked genetic modification of Pichia pastoris [J]. lnterscience, 2009, 9:600-609.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部